FDA alert
FDA alert
11/14/2023
Jessica Ganga
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
Treatment
Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
Neurological Disorders and Diseases
Neurological Disorders and Diseases
04/27/2017
The US Food and Drug Administration has approved a new option for the treatment of a specific form of Batten disease in pediatric patients aged 3 years and older.
04/27/2017
Movement Disorders
Movement Disorders
04/04/2017
The US Food and Drug Administration has approved Austedo (deutetrabenazine) tablets for the treatment of chorea in patients with Huntington disease.
04/04/2017